|
Instructions
ICCB-Longwood welcomes applications from Harvard Medical School (HMS), Harvard Hospital-affiliated investigators. Applications
must be submitted each time a new screen is proposed. We are currently accepting applications on a rolling basis. If the facility becomes oversubscribed we will institute a waiting list.
Note that, as of October 1, 2005, a fee is charged for access to small molecule screening at ICCB-Longwood. This fee helps us to recover some of our operating costs. It is revised annually on a schedule based on the Harvard fiscal year (July 1 - June 30), thus updates to the fee structure are generally posted here in the late summer. Please contact Caroline Shamu with questions regarding fee revisions.
(Fees updated August 18, 2008) For HMS Quadrangle-based investigators, the small molecule screening fee is $5,070 per screen. For HMS-affiliated investigators whose labs are not located on the HMS quadrangle, the small molecule screening fee is $6,220 ($1,150 of this amount is a charge to cover facilities and administration costs assessed by HMS). For investigators with no HMS affiliation, the fee is $10,220 ($1,150 of this amount is a charge to cover facilities and administration costs assessed by HMS). Interested screeners should contact Caroline Shamu for more details and/or to determine which rate applies to their screen. The fee is in addition to the cost of assay reagents and supplies provided by the screener. The fee will be charged only once screening is underway and not during the development phase of the screen. Please contact Caroline Shamu if you have any questions.
Before screening, you will also need to agree to the ICCB-Longwood protocol
and data sharing policies outlined in the ICCB-Longwood Data Sharing Agreement.
We must have a signed Data Sharing Agreement for each collaborator
before use of the Screening Facility is scheduled. If possible,
please submit the signed Agreement at the same time as the completed
Application.
(Download
Data Sharing Agreement (PDF))
For more information about working at ICCB-Longwood to carry
out small molecule screening projects, please see our website, http://iccb.med.harvard.edu.
Note that we do our best not to initiate collaborations that compete
with existing ones. Therefore, we avoid situations in which two
different groups are carrying out substantially similar screens
on the same compound collections at the same time. The decision
as to whether a proposed screen will compete with ongoing assays
is made by the ICCB-Longwood Screen Review Committee in consultation with the investigators
involved. Precedence is generally given to the screen first proposed
and to those proposed by ICCB-Longwood members.
Often, investigators request a Letter of Collaboration for grants
intended to fund a screen. Please understand that we can only write
such a letter if we know that we can accommodate your screen. Therefore,
please try to submit your Application to screen at the ICCB-Longwood well
in advance of grant deadlines, and please warn us if you expect
to need a Letter of Collaboration.
Please send any questions about the ICCB-Longwood Screening Application
or evaluation process to screeniccb_apply"AT"hms.harvard.edu.
If you think you are having problems submitting an Application via this website, please send an explanatory email directly to screeniccb_apply@hms.harvard.edu or to the Director of ICCB-Longwood. Thank you.
|
